429 related articles for article (PubMed ID: 9257424)
1. Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment.
Guchelaar HJ; Vermes A; Meerwaldt JH
Support Care Cancer; 1997 Jul; 5(4):281-8. PubMed ID: 9257424
[TBL] [Abstract][Full Text] [Related]
2. Pathophysiology and management of radiation-induced xerostomia.
Berk LB; Shivnani AT; Small W
J Support Oncol; 2005; 3(3):191-200. PubMed ID: 15915820
[TBL] [Abstract][Full Text] [Related]
3. Buccal drug delivery technologies for patient-centred treatment of radiation-induced xerostomia (dry mouth).
Malallah OS; Garcia CMA; Proctor GB; Forbes B; Royall PG
Int J Pharm; 2018 Apr; 541(1-2):157-166. PubMed ID: 29425763
[TBL] [Abstract][Full Text] [Related]
4. Manifestations and treatment of xerostomia and associated oral effects secondary to head and neck radiation therapy.
Garg AK; Malo M
J Am Dent Assoc; 1997 Aug; 128(8):1128-33. PubMed ID: 9260423
[TBL] [Abstract][Full Text] [Related]
5. Phase 1 clinical study of cell therapy with effective-mononuclear cells (E-MNC) for radiogenic xerostomia (first-in-human study) (FIH study on E-MNC therapy for radiogenic xerostomia).
Sumita Y; Iwamoto N; Seki M; Yoshida T; Honma R; Iwatake M; Ohba S; Takashi I; Hotokezaka Y; Harada H; Kuroshima S; Nagai K; Asahara T; Atsushi Kawakam I; Asahina I
Medicine (Baltimore); 2020 Jun; 99(26):e20788. PubMed ID: 32590759
[TBL] [Abstract][Full Text] [Related]
6. Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia.
Wiseman LR; Faulds D
Drugs; 1995 Jan; 49(1):143-55. PubMed ID: 7705213
[TBL] [Abstract][Full Text] [Related]
7. Acquired salivary dysfunction. Drugs and radiation.
Fox PC
Ann N Y Acad Sci; 1998 Apr; 842():132-7. PubMed ID: 9599303
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and economic evaluation of pilocarpine in treating radiation-induced xerostomia.
Taylor SE
Expert Opin Pharmacother; 2003 Sep; 4(9):1489-97. PubMed ID: 12943478
[TBL] [Abstract][Full Text] [Related]
9. The prevention and treatment of radiotherapy - induced xerostomia.
Eisbruch A; Rhodus N; Rosenthal D; Murphy B; Rasch C; Sonis S; Scarantino C; Brizel D
Semin Radiat Oncol; 2003 Jul; 13(3):302-8. PubMed ID: 12903018
[TBL] [Abstract][Full Text] [Related]
10. Management of salivary hypofunction during and after radiotherapy.
Shiboski CH; Hodgson TA; Ship JA; Schiødt M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S66.e1-19. PubMed ID: 17379158
[TBL] [Abstract][Full Text] [Related]
11. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies.
Nieuw Amerongen AV; Veerman EC
Support Care Cancer; 2003 Apr; 11(4):226-31. PubMed ID: 12673460
[TBL] [Abstract][Full Text] [Related]
12. Preemptive pharmacologic intervention in radiation-induced salivary dysfunction.
Taylor SE; Miller EG
Proc Soc Exp Biol Med; 1999 May; 221(1):14-26. PubMed ID: 10320627
[TBL] [Abstract][Full Text] [Related]
13. Xerostomia: diagnosis and management.
Greenspan D
Oncology (Williston Park); 1996 Mar; 10(3 Suppl):7-11. PubMed ID: 8723427
[TBL] [Abstract][Full Text] [Related]
14. Clinical management of salivary gland hypofunction and xerostomia in head-and-neck cancer patients: successes and barriers.
Vissink A; Mitchell JB; Baum BJ; Limesand KH; Jensen SB; Fox PC; Elting LS; Langendijk JA; Coppes RP; Reyland ME
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):983-91. PubMed ID: 20970030
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
Rhodus NL; Bereuter J
J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
[TBL] [Abstract][Full Text] [Related]
16. Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients.
de Castro G; Federico MH
Curr Opin Oncol; 2006 May; 18(3):266-70. PubMed ID: 16552239
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of effect of transcutaneous electrical nerve stimulation on salivary flow rate in radiation induced xerostomia patients: a pilot study.
Lakshman AR; Babu GS; Rao S
J Cancer Res Ther; 2015; 11(1):229-33. PubMed ID: 25879367
[TBL] [Abstract][Full Text] [Related]
18. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management.
Chambers MS; Garden AS; Kies MS; Martin JW
Head Neck; 2004 Sep; 26(9):796-807. PubMed ID: 15350026
[TBL] [Abstract][Full Text] [Related]
19. Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry.
Valdez IH; Atkinson JC; Ship JA; Fox PC
Int J Radiat Oncol Biol Phys; 1993 Jan; 25(1):41-7. PubMed ID: 8416881
[TBL] [Abstract][Full Text] [Related]
20. The role of saliva in oral health: strategies for prevention and management of xerostomia.
Brosky ME
J Support Oncol; 2007 May; 5(5):215-25. PubMed ID: 17564151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
